MORGAN STANLEY PLC/CALL/STRYKER CORP./440/0.1/20.12.24 Stock

Warrant

DE000MB5S5Y1

Market Closed - Börse Stuttgart 15:23:59 2024-05-27 EDT
0.19 EUR -7.77% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./440/0.1/20.12.24
Current month-38.71%
1 month-36.67%
Date Price Change
24-05-27 0.19 -7.77%
24-05-24 0.206 +8.99%
24-05-23 0.189 -2.58%
24-05-22 0.194 +9.60%
24-05-21 0.177 -2.75%

Delayed Quote Börse Stuttgart

Last update May 27, 2024 at 03:23 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MB5S5Y
ISINDE000MB5S5Y1
Date issued 2023-04-21
Strike 440 $
Maturity 2024-12-20 (207 Days)
Parity 10 : 1
Emission price 0.74
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.36
Lowest since issue 0.12
Spread 0.07
Spread %26.92%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.5 USD
Average target price
372.4 USD
Spread / Average Target
+10.97%
Consensus